THE RECEPTOR TYROSINE KINASES ROR1 AND ROR2 EXPRESSION PATTERNS IN LYMPHOID AND MYELOID MALIGNANCIES

被引：0

作者：

Manesh, A. Danesh ^{[1
]}

Porwit, A. ^{[2
]}

Hojjat-Farsangi, M. ^{[3
]}

Jeddi-Tehrani, M. ^{[4
]}

Tamm, K. Pokrovskaja ^{[3
]}

Grander, D. ^{[3
]}

Lehmann, S. ^{[5
]}

Norin, S. ^{[5
]}

Shokri, F. ^{[6
]}

Rabbani, H. ^{[3
]}

Mellstedt, H. ^{[3
]}

Osterborg, A. ^{[7
,8
]}

机构：

[1] Karolinska Inst, Stockholm, Sweden

[2] Univ Hlth Network, Dept Lab Med & Pathol, Toronto, ON, Canada

[3] Karolinska Inst, CCK, Dept Oncol & Pathol, Stockholm, Sweden

[4] Avicenna Res Inst ACECR, Monoclonal Antibody Res Ctr, Tehran, Iran

[5] Karolinska Univ Hosp Huddinge, Hematol Ctr, Stockholm, Sweden

[6] Univ Tehran Med Sci, Dept Immunol, Tehran, Iran

[7] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden

[8] Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden

来源：

HAEMATOLOGICA | 2012年 / 97卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1277

引用

页码：520 / 520

页数：1

共 50 条

[21] Evolutionary Divergence in the Catalytic Activity of the CAM-1, ROR1 and ROR2 Kinase Domains
Bainbridge, Travis W.
DeAlmeida, Venita I.
Izrael-Tomasevic, Anita
Chalouni, Cecile
Pan, Borlan
Goldsmith, Joshua
Schoen, Alia P.
Quinones, Gabriel A.
Kelly, Ryan
Lill, Jennie R.
Sandoval, Wendy
Costa, Mike
Polakis, Paul
Arnott, David
Rubinfeld, Bonnee
Ernst, James A.
[J]. PLOS ONE, 2014, 9 (07):
[22] New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome
Juuli Raivola
Alice Dini
Kari Salokas
Hanna Karvonen
Wilhelmiina Niininen
Emilia Piki
Markku Varjosalo
Daniela Ungureanu
[J]. Cellular and Molecular Life Sciences, 2022, 79
[23] Correction to: Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
C. E. Henry
E. Llamosas
A. Djordjevic
N. F. Hacker
C. E. Ford
[J]. Oncogenesis, 11
[24] Pan-Tissue and -Cancer Analysis of ROR1 and ROR2 Transcript Variants Identify Novel Functional Significance for an Alternative Splice Variant of ROR1
John, Miya
Ford, Caroline E.
[J]. BIOMEDICINES, 2022, 10 (10)
[25] Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation
Yu, Jian
Chen, Liguang
Cui, Bing
Widhopf, George F., II
Shen, Zhouxin
Wu, Rongrong
Zhang, Ling
Zhang, Suping
Briggs, Steven P.
Kipps, Thomas J.
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (02): : 585 - 598
[26] Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis
Henry, Claire
Hacker, Neville
Ford, Caroline
[J]. ONCOTARGET, 2017, 8 (68) : 112727 - 112738
[27] Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion
Henry, Claire
Llamosas, Estelle
Knipprath-Meszaros, Alexandra
Schoetzau, Andreas
Obermann, Ellen
Fuenfschilling, Maya
Caduff, Rosemarie
Fink, Daniel
Hacker, Neville
Ward, Robyn
Heinzelmann-Schwarz, Viola
Ford, Caroline
[J]. ONCOTARGET, 2015, 6 (37) : 40310 - 40326
[28] Gene expression analyses of receptor tyrosine kinases identify ROR1 as a potential therapeutic target in metastatic Ewing sarcoma
Berning, P.
Tillmanns, A.
Korsching, E.
Lechtape, B.
Schaefer, C.
Schleithoff, C.
Schaefer, K. -L
Dirksen, U.
Potratz, J.
[J]. Oncology Research and Treatment, 2015, 38 : 247 - 247
[29] Restricted expression of the orphan tyrosine kinase receptor ROR1 in chronic lymphocytic leukemia
Carson, DA
Kipps, TJ
[J]. BLOOD, 2004, 104 (11) : 221A - 221A
[30] Extracellular vesicle-associated tyrosine kinase-like orphan receptors ROR1 and ROR2 promote breast cancer progression
Irmer, Barnabas
Efing, Janes
Reitnauer, Lea Elisabeth
Angenendt, Allegra
Heinrichs, Saskia
Schubert, Antonia
Schulz, Matthias
Binder, Claudia
Tio, Joke
Hansen, Uwe
Geyer, Christiane
Gerwing, Mirjam
Bleckmann, Annalen
Menck, Kerstin
[J]. CELL COMMUNICATION AND SIGNALING, 2023, 21 (01)

← 1 2 3 4 5 →